FDA Approved: TRYNGOLZA — Original Application (Ionis Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves TRYNGOLZA (olesarsen sodium) from Ionis Pharmaceuticals as a new molecular entity for the treatment of severe hypertriglyceridemia, including famil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Chylomicronemia Syndrome
• Hypertriglyceridemia

Drugs mentioned

• TRYNGOLZA (olesarsen sodium)

Snippet

ORIG AP for TRYNGOLZA (OLEZARSEN SODIUM)